Past CureTalks
Bridging the Gap in Multiple Myeloma Survival
What is the gap in myeloma survival? Currently the National Cancer Institute reports a life expectancy of just over five years, whereas, myeloma specialists at myeloma centers of excellence have reported a life expectancy of over ten years for myeloma…
What’s New in Multiple Myeloma Management?
Multiple myeloma is diagnosed in over 100,000 patients each year worldwide. The FDA recently granted accelerated approval to Teclistamab, the first bispecific B-cell maturation (BCMA)-directed CD3 T-cell engager. The therapeutic armamentarium for myeloma now includes alkylating agents, corticosteroids, deacetylase inhibitors,…
Understanding the Effects of Space Missions on Human Health and Behavior
Space scientists speculate that we will likely set foot on mars in the next two decades, yet we know little about how our brains and bodies change and respond to the space environment and the use of medications that go…
Transforming Multiple Sclerosis Care Through Precision Medicine
Multiple sclerosis (MS) is a neurological condition where the immune system attacks the nerve fibers thereby affecting the functions of the brain and spinal cord. It affects about 2.8 million people worldwide and leads to symptoms that can vary from…
Beyond CAR-T: Re-engineering Cells into Life-saving Therapies
Our cells have the innate ability to protect us. The idea of using cells as medicine emerged with bone marrow transplants, and then CAR-T therapy for blood cancers. Now, scientists are beginning to engineer much more complex living therapeutics by…